This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The Feinstein Institutes for Medical Research. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2017
Title: Innovations by Inventor Bradley T. Messmer
Introduction
Bradley T. Messmer is a notable inventor based in La Jolla, California. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of B cell chronic lymphocytic leukemia (B-CLL). With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from this condition.
Latest Patents
Messmer's latest patents focus on innovative methods and compositions for the diagnosis and treatment of B-CLL. One of his inventions provides an anti-idiotype antibody that binds to the antigen-binding region of an antibody encoded by specific antibody genes. This invention includes hybridomas and methods of treatment using such antibodies. Another patent offers isolated and purified preparations of a combination of light chain and heavy chain antibody genes, which are consistent among multiple patients with B-CLL. This patent also includes vectors comprising those genes and cells containing those vectors, as well as isolated and purified antibodies encoded by the antibody genes. Furthermore, it provides anti-idiotype antibodies, peptides, and aptamers that bind to the antigen-binding region of the antibody genes. Methods for determining the susceptibility of B-CLL forms to treatment and for tracking treatment progression are also included in his patents.
Career Highlights
Bradley T. Messmer is affiliated with the Feinstein Institute for Medical Research, where he conducts his research and develops his innovative solutions. His work is crucial in advancing the understanding and treatment of B-CLL, a challenging form of leukemia.
Collaborations
Messmer collaborates with esteemed colleagues such as Nicholas Chiorazzi and Emilia Albesiano, contributing to a collective effort in medical research and innovation.
Conclusion
Bradley T. Messmer's contributions to the field of medical research through his patents and collaborations highlight his commitment to improving treatment options for patients with B-CLL. His innovative approaches are paving the way for advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile